Page last updated: 2024-08-23

bromocriptine and medroxyprogesterone acetate

bromocriptine has been researched along with medroxyprogesterone acetate in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19906 (60.00)18.7374
1990's1 (10.00)18.2507
2000's1 (10.00)29.6817
2010's1 (10.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Dauvois, S; Labrie, F; Spinola, PG1
Abel, U; Edler, L; Fritze, D; Kaufmann, M; Massner, B; Queisser, W; Schmid, H; Schmidt, R; Westerhausen, M1
Bellussi, G; Conti, G; Di Carlo, F; Muccioli, G; Racca, S1
Farabegoli, G; Martoni, A; Pannuti, F; Piana, E1
Huber, H; Schmidt, JB; Spona, J1
Kauppila, A1
Carpenter, PC; Turk, DM1
Cohen, JR; Dragon, JA; Famula, TR; Horigan, KC; Hovey, RC; Lemay, DG; Schennink, A; Trott, JF1

Reviews

1 review(s) available for bromocriptine and medroxyprogesterone acetate

ArticleYear
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
    Acta obstetricia et gynecologica Scandinavica, 1984, Volume: 63, Issue:5

    Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms

1984

Trials

1 trial(s) available for bromocriptine and medroxyprogesterone acetate

ArticleYear
Prospective randomized trial concerning hyper- and normoprolactinemia and the use of bromoergocryptine in patients with metastatic breast cancer.
    Onkologie, 1986, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Hyperprolactinemia; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Prolactin; Vincristine

1986

Other Studies

8 other study(ies) available for bromocriptine and medroxyprogesterone acetate

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:5

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Drug Synergism; Female; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Rats; Rats, Inbred Strains; Receptors, Estrogen; Receptors, Progesterone

1989
High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer.
    International journal of cancer, 1988, May-15, Volume: 41, Issue:5

    Topics: Adenocarcinoma; Animals; Bromocriptine; Female; Liver; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Prolactin; Rats; Rats, Inbred Strains; Receptor, Insulin; Receptors, Prolactin

1988
Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1985, Volume: 4, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Delayed-Action Preparations; Estradiol; Female; Gonadotropins, Pituitary; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prolactin; Tamoxifen; Testosterone; Thyroid Hormones

1985
[Therapeutic possibilities in hirsutism].
    Gynakologische Rundschau, 1984, Volume: 24, Issue:3

    Topics: Androgens; Bromocriptine; Dexamethasone; Female; Hirsutism; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate

1984
Hirsutism.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Androgen Antagonists; Bromocriptine; Contraceptives, Oral, Combined; Dexamethasone; Female; Finasteride; Goserelin; Hirsutism; Humans; Ketoconazole; Leuprolide; Medroxyprogesterone Acetate; Nafarelin

1994
Unique Transcriptomic Changes Underlie Hormonal Interactions During Mammary Histomorphogenesis in Female Pigs.
    Endocrinology, 2022, 03-01, Volume: 163, Issue:3

    Topics: Animals; Bromocriptine; Drug Synergism; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Haloperidol; Mammary Glands, Animal; Medroxyprogesterone Acetate; Models, Animal; Morphogenesis; Ovariectomy; Progesterone; Prolactin; Receptors, Progesterone; Swine; Swine, Miniature; Transcriptome

2022